Physician profile
L J Kennington
NPI 1215903406
$1,116.04
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $919 · 2020: $180 · 2021: $17.22.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $263.87 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $203.93 | 2019-2020 | |
| Glaxosmithkline, LLC. | $149.13 | 2019 | |
| Amarin Pharma, INC. | $123.14 | 2019 | |
| Abbvie INC. | $65.83 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $53.89 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.04 | 2019 | |
| Shire North American Group INC | $41.94 | 2019 | |
| Sanofi Pasteur INC. | $31.83 | 2019-2020 | |
| Novo Nordisk INC | $28.06 | 2019 | |
| Novartis Pharmaceuticals Corporation | $26.99 | 2019 | |
| Pfizer INC. | $25.09 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $22.38 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.33 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.37 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $11.22 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw L Kennington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.